Information  X 
Enter a valid email address

Lakehouse plc (SUR)

  Print      Mail a friend

Monday 20 August, 2018

Lakehouse plc

Director/PDMR Shareholding

RNS Number : 2716Y
Lakehouse plc
20 August 2018
 

20 August 2018

 

Lakehouse plc (the "Company")

 

Notification of Transaction by Directors/PDMRs

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities (PDMR's)  and persons closely associated with them. Robert Holt has a total beneficial interest in 100,000 Ordinary Shares, representing 0.06% of the issued share capital of the Company.

               

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

 

Name

 

Robert Holt

2

Reason for the notification

 

a)

 

Position/status

Chairman (PDMR )

 

b)

 

Initial notification/ Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Lakehouse plc

 

b)

 

LEI

213800FHUTNVX8LWPH50

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument Identification code

Purchase of ordinary shares of 10p each in the capital of Lakehouse plc ( " Shares " )

 

b)

 

Nature of the transaction

Purchase of shares

 

c)

 

Price(s) and volume(s)

 

 

 

41.25p

100,000

d)

Aggregated information

- Aggregated price

- Aggregated volume

- Aggregated total

N/A - single transaction

 

e)

 

Date of the transaction

18 August 2018

 

f)

 

Place of the transaction

United Kingdom

g)

Additional Information

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHEAXPEAESPEEF

a d v e r t i s e m e n t